296 related articles for article (PubMed ID: 32132543)
1. Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension.
Sindi HA; Russomanno G; Satta S; Abdul-Salam VB; Jo KB; Qazi-Chaudhry B; Ainscough AJ; Szulcek R; Jan Bogaard H; Morgan CC; Pullamsetti SS; Alzaydi MM; Rhodes CJ; Piva R; Eichstaedt CA; Grünig E; Wilkins MR; Wojciak-Stothard B
Nat Commun; 2020 Mar; 11(1):1185. PubMed ID: 32132543
[TBL] [Abstract][Full Text] [Related]
2. miR-182-3p/Myadm contribute to pulmonary artery hypertension vascular remodeling via a KLF4/p21-dependent mechanism.
Sun L; Lin P; Chen Y; Yu H; Ren S; Wang J; Zhao L; Du G
Theranostics; 2020; 10(12):5581-5599. PubMed ID: 32373233
[No Abstract] [Full Text] [Related]
3. In vivo miR-138-5p inhibition alleviates monocrotaline-induced pulmonary hypertension and normalizes pulmonary KCNK3 and SLC45A3 expression.
Le Ribeuz H; Courboulin A; Ghigna MR; Lambert M; Hautefort A; Humbert M; Montani D; Cohen-Kaminsky S; Perros F; Antigny F
Respir Res; 2020 Jul; 21(1):186. PubMed ID: 32678044
[TBL] [Abstract][Full Text] [Related]
4. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
5. Transpulmonary Expression of Exosomal microRNAs in Idiopathic and Congenital Heart Disease-Related Pulmonary Arterial Hypertension.
Chang WT; Lee WC; Lin YW; Shih JY; Hong CS; Chen ZC; Chu CY; Hsu CH
J Am Heart Assoc; 2023 Dec; 12(23):e031435. PubMed ID: 38014665
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.
Deng L; Blanco FJ; Stevens H; Lu R; Caudrillier A; McBride M; McClure JD; Grant J; Thomas M; Frid M; Stenmark K; White K; Seto AG; Morrell NW; Bradshaw AC; MacLean MR; Baker AH
Circ Res; 2015 Oct; 117(10):870-883. PubMed ID: 26311719
[TBL] [Abstract][Full Text] [Related]
7. Exosomes enriched by miR-429-3p derived from ITGB1 modified Telocytes alleviates hypoxia-induced pulmonary arterial hypertension through regulating Rac1 expression.
Qi R; Zhang Y; Yan F
Cell Biol Toxicol; 2024 May; 40(1):32. PubMed ID: 38767703
[TBL] [Abstract][Full Text] [Related]
8. miR-181a/b-5p ameliorates inflammatory response in monocrotaline-induced pulmonary arterial hypertension by targeting endocan.
Zhao H; Guo Y; Sun Y; Zhang N; Wang X
J Cell Physiol; 2020 May; 235(5):4422-4433. PubMed ID: 31637717
[TBL] [Abstract][Full Text] [Related]
9. MiR-18a-5p contributes to enhanced proliferation and migration of PASMCs via targeting Notch2 in pulmonary arterial hypertension.
Miao R; Liu W; Qi C; Song Y; Zhang Y; Fu Y; Liu W; Lang Y; Zhang Y; Zhang Z
Life Sci; 2020 Sep; 257():117919. PubMed ID: 32585247
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-140-5p targeting tumor necrosis factor-α prevents pulmonary arterial hypertension.
Zhu TT; Zhang WF; Yin YL; Liu YH; Song P; Xu J; Zhang MX; Li P
J Cell Physiol; 2019 Jun; 234(6):9535-9550. PubMed ID: 30367500
[TBL] [Abstract][Full Text] [Related]
11. Matrix stiffening induces a pathogenic QKI-miR-7-SRSF1 signaling axis in pulmonary arterial endothelial cells.
Woodcock CC; Hafeez N; Handen A; Tang Y; Harvey LD; Estephan LE; Speyer G; Kim S; Bertero T; Chan SY
Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L726-L738. PubMed ID: 33565360
[TBL] [Abstract][Full Text] [Related]
12. MiR-449a-5p mediates mitochondrial dysfunction and phenotypic transition by targeting Myc in pulmonary arterial smooth muscle cells.
Zhang C; Ma C; Zhang L; Zhang L; Zhang F; Ma M; Zheng X; Mao M; Shen T; Zhu D
J Mol Med (Berl); 2019 Mar; 97(3):409-422. PubMed ID: 30715622
[TBL] [Abstract][Full Text] [Related]
13. MiR-593-5p promotes the development of hypoxic-induced pulmonary hypertension via targeting PLK1.
Zhao TF; Wang SY; Zou XZ; Zhao HD
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3495-3502. PubMed ID: 31081105
[TBL] [Abstract][Full Text] [Related]
14. Silence of miR-32-5p promotes endothelial cell viability by targeting KLF2 and serves as a diagnostic biomarker of acute myocardial infarction.
Dai Y; Yan T; Gao Y
Diagn Pathol; 2020 Mar; 15(1):19. PubMed ID: 32127011
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of miR-340-5p Inhibits Skin Fibroblast Proliferation by Targeting Kruppel-like Factor 2.
Chen L; Li Q; Lu X; Dong X; Li J
Curr Pharm Biotechnol; 2019; 20(13):1147-1154. PubMed ID: 31345144
[TBL] [Abstract][Full Text] [Related]
16. MiR-125a-5p ameliorates monocrotaline-induced pulmonary arterial hypertension by targeting the TGF-β1 and IL-6/STAT3 signaling pathways.
Cai Z; Li J; Zhuang Q; Zhang X; Yuan A; Shen L; Kang K; Qu B; Tang Y; Pu J; Gou D; Shen J
Exp Mol Med; 2018 Apr; 50(4):1-11. PubMed ID: 29700287
[TBL] [Abstract][Full Text] [Related]
17. miR-190a-5p participates in the regulation of hypoxia-induced pulmonary hypertension by targeting KLF15 and can serve as a biomarker of diagnosis and prognosis in chronic obstructive pulmonary disease complicated with pulmonary hypertension.
Jiang J; Xia Y; Liang Y; Yang M; Zeng W; Zeng X
Int J Chron Obstruct Pulmon Dis; 2018; 13():3777-3790. PubMed ID: 30538440
[TBL] [Abstract][Full Text] [Related]
18. Adipose-derived mesenchymal stromal cells improve hemodynamic function in pulmonary arterial hypertension: identification of microRNAs implicated in modulating endothelial function.
Wang P; Zhang C; Li J; Luo L; Zhang S; Dong F; Tang Z; Ni S
Cytotherapy; 2019 Apr; 21(4):416-427. PubMed ID: 30904330
[TBL] [Abstract][Full Text] [Related]
19. N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension.
Kang K; Xiang J; Zhang X; Xie Y; Zhou M; Zeng L; Zhuang J; Kuang J; Lin Y; Hu B; Xiong Q; Yin Q; Su Q; Liao X; Wang J; Niu Y; Liu C; Tian J; Gou D
Cell Mol Biol Lett; 2024 May; 29(1):69. PubMed ID: 38741032
[TBL] [Abstract][Full Text] [Related]
20. MircoRNA in Extracellular Vesicles from Patients with Pulmonary Arterial Hypertension Alters Endothelial Angiogenic Response.
Khandagale A; Corcoran P; Nikpour M; Isaksson A; Wikström G; Siegbahn A; Christersson C
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
